Association of an APOC3 promoter variant with type 2 diabetes risk and need for insulin treatment in lean persons

AIMS/HYPOTHESIS: An APOC3 promoter haplotype has been previously associated with type 1 diabetes. In this population-based study, we investigated whether APOC3 polymorphisms increase type 2 diabetes risk and need for insulin treatment in lean participants. METHODS: In the Rotterdam Study, a populati...

Descripción completa

Detalles Bibliográficos
Autores principales: van Hoek, M., van Herpt, T. W., Dehghan, A., Hofman, A., Lieverse, A. G., van Duijn, C. M., Witteman, J. C. M., Sijbrands, E. J. G.
Formato: Texto
Lenguaje:English
Publicado: Springer-Verlag 2011
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3088807/
https://www.ncbi.nlm.nih.gov/pubmed/21373834
http://dx.doi.org/10.1007/s00125-011-2092-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3088807/
https://www.ncbi.nlm.nih.gov/pubmed/21373834
http://dx.doi.org/10.1007/s00125-011-2092-x

Ejemplares similares